Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)

Active, not recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Kidney Transplant InfectionSARS-CoV Infection

Interventions

DRUG

SARS-CoV-2 vaccine

SARS-CoV-2 vaccines currently on market, i.e. Pfizer/BioNTech and Moderna

Trial Locations (1)

Oslo University Hospital, Oslo

All Listed Sponsors

lead

Oslo University Hospital

OTHER